Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eleven Biotherapeutics
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Give written informed consent and any authorizations required by local law (e.g., Protected Health Information waiver) prior to performing any study procedures;
Are ≥ 18 years of age;
Are willing and able to follow instructions and can be present for the required study visits for the duration of the study;
Have a history of dry eye disease (DED) in both eyes supported by a previous clinical diagnosis
Have normal lid anatomy.
If female and of child bearing potential, she must not be not pregnant or lactating and not sexually active (abstinent) within 14 days prior to Visit 1
You may not be if
Have signs of infection (i.e., fever or current treatment with antibiotics)
Have been exposed to an investigational drug/device within the preceding 30 days
Be an employee of the site that is directly involved in the management, administration, or support of the study, or be an immediate family member of the same
Be unwilling to or unable to comply with the study
Clareo Health | Phase 3 Study of EBI-005 in Dry Eye Disease
